Department of Public Health and Primary Care, KU Leuven - University of Leuven, Kapucijnenvoer 35 (box 7001), 3000, Leuven, Belgium.
Research Foundation Flanders (FWO), 1000, Brussels, Belgium.
Eur Heart J. 2022 Nov 7;43(42):4483-4492. doi: 10.1093/eurheartj/ehac484.
Although life expectancy in adults with congenital heart diseases (CHD) has increased dramatically over the past five decades, still a substantial number of patients dies prematurely. To gain understanding in the trajectories of dying in adults with CHD, the last year of life warrants further investigation. Therefore, our study aimed to (i) define the causes of death and (ii) describe the patterns of healthcare utilization in the last year of life of adults with CHD.
This retrospective mortality follow-back study used healthcare claims and clinical data from BELCODAC, which includes patients with CHD from Belgium. Healthcare utilization comprises cardiovascular procedures, CHD physician contacts, general practitioner visits, hospitalizations, emergency department (ED) visits, intensive care unit (ICU) admissions, and specialist palliative care, and was identified using nomenclature codes. Of the 390 included patients, almost half of the study population (45%) died from a cardiovascular cause. In the last year of life, 87% of patients were hospitalized, 78% of patients had an ED visit, and 19% of patients had an ICU admission. Specialist palliative care was provided to 17% of patients, and to only 4% when looking at the patients with cardiovascular causes of death.
There is a high use of intensive and potentially avoidable care at the end of life. This may imply that end-of-life care provision can be improved. Future studies should further examine end-of-life care provision in the light of patient's needs and preferences, and how the healthcare system can adequately respond.
尽管在过去的五十年中,先天性心脏病(CHD)患者的预期寿命显著延长,但仍有相当数量的患者过早死亡。为了了解 CHD 患者临终过程的轨迹,有必要进一步研究其生命的最后一年。因此,我们的研究旨在:(i)确定死亡原因;(ii)描述 CHD 患者生命最后一年的医疗保健利用模式。
这项回顾性死亡率随访研究使用了 BELCODAC 的医疗保健索赔和临床数据,该数据库包含来自比利时的 CHD 患者。医疗保健利用包括心血管程序、CHD 医生就诊、全科医生就诊、住院、急诊(ED)就诊、重症监护病房(ICU)入院和专科姑息治疗,并使用命名法代码识别。在 390 名纳入的患者中,近一半(45%)的患者死于心血管原因。在生命的最后一年,87%的患者住院,78%的患者 ED 就诊,19%的患者 ICU 入院。17%的患者接受了专科姑息治疗,而心血管原因死亡的患者中只有 4%接受了该治疗。
生命末期高强度和潜在可避免的医疗保健利用很高。这可能意味着临终关怀服务的提供可以得到改善。未来的研究应进一步根据患者的需求和偏好,以及医疗保健系统如何做出充分反应,来研究临终关怀服务的提供情况。